Citius Oncology, Inc. (CTOR) stock
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.56+0.01 (+1.79%)
Close on Nov 18, 2026Market cap $51.83MP/E –Yield –
Citius Oncology gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $1.00M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $1.34M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $3.15M | – |
See a number that looks wrong?